logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
VERU
Veru Inc.
2.31
1 x 2.30
7 x 2.32
bid
ask
-
0.03
1.28%
01:20 PM
timesize
Ytd7.94%
1y-59.47%
2.27
day range
2.35
2.05
52 week range
7.33
Open2.32Prev Close2.34Low2.27High2.35Mkt Cap37.56M
Vol134.01KAvg Vol1.96MEPS-1.49P/E-1.57Forward P/E-2.23
Beta-1.19Short Ratio13.35Inst. Own42.04%DividendN/ADiv YieldN/A
Ex Div Date04-28Earning08-1250-d Avg2.67200-d Avg2.651yr Est3.40

VERU News

Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
globenewswire.com
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Da

MIAMI, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar
benzinga.com
Veru Strikes Clinical Supply Agreement With Novo Nordisk To Mull Combination Of Enobosarm With Wegov

https://www.sec.gov/ix?doc=/Archives/edgar/data/863894/000143774926019478/veru20260601_8k.htm

Veru Inc. (VERU) Q2 2026 Earnings Call Prepared Remarks Transcript
seekingalpha.com
Veru Inc. (VERU) Q2 2026 Earnings Call Prepared Remarks Transcript

Veru Inc. (VERU) Q2 2026 Earnings Call Prepared Remarks Transcript

Earnings Scheduled For May 13, 2026
benzinga.com
Earnings Scheduled For May 13, 2026

Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
globenewswire.com
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progre

--Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on tr

Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th
globenewswire.com
Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th

MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharm

Veru (NASDAQ:VERU) Share Price Crosses Below 200 Day Moving Average – Here’s Why
defenseworld.net
Veru (NASDAQ:VERU) Share Price Crosses Below 200 Day Moving Average – Here’s Why

Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price crossed below its 200-day moving average du

Veru (NASDAQ:VERU) Stock Passes Below 200 Day Moving Average – Should You Sell?
defenseworld.net
Veru (NASDAQ:VERU) Stock Passes Below 200 Day Moving Average – Should You Sell?

Veru Inc. (NASDAQ: VERU - Get Free Report) shares passed below its 200-day moving average during tra

Veru (NASDAQ:VERU) Shares Cross Below 200 Day Moving Average – Here’s Why
defenseworld.net
Veru (NASDAQ:VERU) Shares Cross Below 200 Day Moving Average – Here’s Why

Veru Inc. (NASDAQ: VERU - Get Free Report)'s stock price passed below its 200-day moving average dur

Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
globenewswire.com
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combinati

-- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bo

Veru Inc. (VERU) Q1 2026 Earnings Call Transcript
seekingalpha.com
Veru Inc. (VERU) Q1 2026 Earnings Call Transcript

Veru Inc. (VERU) Q1 2026 Earnings Call Transcript

Earnings Scheduled For February 11, 2026
benzinga.com
Earnings Scheduled For February 11, 2026

Flora Growth (NASDAQ:FLGC) and Veru (NASDAQ:VERU) Financial Review
defenseworld.net
Flora Growth (NASDAQ:FLGC) and Veru (NASDAQ:VERU) Financial Review

Veru (NASDAQ: VERU - Get Free Report) and Flora Growth (NASDAQ: FLGC - Get Free Report) are both sma

Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
globenewswire.com
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Veru Inc. (VERU) Q4 2025 Earnings Call Transcript
seekingalpha.com
Veru Inc. (VERU) Q4 2025 Earnings Call Transcript

Veru Inc. (VERU) Q4 2025 Earnings Call Transcript

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
globenewswire.com
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

MIAMI, FL, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

Earnings Scheduled For December 17, 2025
benzinga.com
Earnings Scheduled For December 17, 2025

Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving Average – Here’s Why
defenseworld.net
Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Veru Inc. (NASDAQ: VERU - Get Free Report) shares passed below its 200-day moving average during tra

Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More
benzinga.com
Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More

Investors are prepping for this week's earnings reports which include homebuilders, several appa

Veru to Report Fiscal Year 2025 Financial Results on December 17th
globenewswire.com
Veru to Report Fiscal Year 2025 Financial Results on December 17th

MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

Veru to Present Two Abstracts at ObesityWeek 2025
globenewswire.com
Veru to Present Two Abstracts at ObesityWeek 2025

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

Veru Announces Proposed Public Offering
globenewswire.com
Veru Announces Proposed Public Offering

MIAMI, FL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biophar

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
globenewswire.com
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preserva

MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopha

Veru Announces Novel Modified-Release Oral Formulation for Enobosarm
zacks.com
Veru Announces Novel Modified-Release Oral Formulation for Enobosarm

VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass

Veru Inc. (VERU) Q3 2025 Earnings Call Transcript
seekingalpha.com
Veru Inc. (VERU) Q3 2025 Earnings Call Transcript

Veru Inc. (NASDAQ:VERU ) Q3 2025 Earnings Call August 12, 2025 8:00 AM ET Company Participants K. Ga
benzinga.com
Earnings Scheduled For August 12, 2025
benzinga.com
Earnings Scheduled For May 8, 2025
benzinga.com
Earnings Scheduled For February 13, 2025
benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 311 stocks hit new 52-week lows.
benzinga.com
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday

Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S
benzinga.com
99 Biggest Movers From Yesterday

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday a
benzinga.com
Earnings Scheduled For August 12, 2021

  Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report

benzinga.com
77 Biggest Movers From Yesterday

Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af
benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

Stocks That Hit 52-Week Highs On Tuesday